Flat-rate pricing · Discounts available · All-inclusive pricing No commitment required 100% online · No lab work required · Dose adjustment supported · Free consultation Free shipping · Supplies included · Discreet packaging Semaglutide · Zepbound, Mounjaro, Ozempic, Wegovy Available in all 50 states Pricing varies by pharmacy Auto-renewing plans · $100 cancellation fee Existing prescription required Pharmacy data not disclosedProvider Plans Mounjaro Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $1399.00 $1499.00 10mg $1399 $139.90/mg 5.0mg/wk 20mg/mo $1399.00 $1499.00 20mg $1399 $69.95/mg 7.5mg/wk 30mg/mo $1399.00 $1499.00 30mg $1399 $46.63/mg 10.0mg/wk 40mg/mo $1399.00 $1499.00 40mg $1399 $34.98/mg 12.5mg/wk 50mg/mo $1399.00 $1499.00 50mg $1399 $27.98/mg 15.0mg/wk 60mg/mo $1399.00 $1499.00 60mg $1399 $23.32/mg Sale price included
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $1599.00 $1699.00 10mg $1599 $159.90/mg 5.0mg/wk 20mg/mo $1599.00 $1699.00 20mg $1599 $79.95/mg 7.5mg/wk 30mg/mo $1599.00 $1699.00 30mg $1599 $53.30/mg 10.0mg/wk 40mg/mo $1599.00 $1699.00 40mg $1599 $39.98/mg 12.5mg/wk 50mg/mo $1599.00 $1699.00 50mg $1599 $31.98/mg 15.0mg/wk 60mg/mo $1599.00 $1699.00 60mg $1599 $26.65/mg Sale price included Discounted price applies to new customers only
Provider Details Bring Your Own Rx Dose Adjustments By Provider
Prescription Included No
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Yes
Credit Sale: up to $100 off Starter Sale: $50 off
Insurance Accepted No
HSA/FSA Accepted Not Disclosed
Financing Available Not Disclosed
Sale Yes
LegitScript Certified Yes
HIPAA Compliant Yes
Mobile App No
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping No
Discreet Packaging Yes
Format: Oral Tablet Brands: Ozempic Pen · Wegovy Pen · +2
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Phone (305) 563-9761
Address Not Disclosed
Provider Notes Compliance The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
General 24/7 medical support is offered. Dr. Ruth Cohen is the named provider on product pages.